Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acne Vulgaris
New Jersey Jury Awards $12.9 Million to Three Patients Whose Use of Roche Acne Medication Accutane Found to Cause Severe Bowel Illness
December 5th, 2008
In another major courtroom verdict linking powerful acne medication Accutane with long-term inflammatory bowel disease (IBD), an eight-person jury in Atlantic City has found that pharmaceutical maker Hoffman-La Roche (OTCQX: RHHBY; VTX: ROG.VX) failed to provide adequate warning of the possible condition to three patients who began taking the drug as teenagers and shortly thereafter developed severe forms of IBD. The jury awarded compensatory damages of $12.89 million to be apportioned among the three individuals, now aged in their mid-to-late 20s. The verdict capped a five-week trial in New Jersey State Superior Court and follows a series of recent plaintiffs' wins...
Source: Health Business Week (2008-12-05)
|
